Browse > Article
http://dx.doi.org/10.12750/JET.2018.33.4.229

Inhibition of Polo-like Kinase 1 Prevents the Male Pronuclear Formation Via Alpha-tubulin Recruiting in In vivo-fertilized Murine Embryos  

Moon, Jeonghyeon (Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, BK21, Seoul National University School of Dentistry)
Roh, Sangho (Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, BK21, Seoul National University School of Dentistry)
Publication Information
Journal of Embryo Transfer / v.33, no.4, 2018 , pp. 229-235 More about this Journal
Abstract
Polo-like kinase 1 (Plk1) has been known to be a critical element in cell division including centrosome maturation, cytokinesis and spindle formation in somatic, cancer, and mammalian embryonic cells. In particular, Plk1 is highly expressed in cancer cells. Plk1 inhibitors, such as BI2536, have been widely used to prevent cell division as an anticancer drug. In this study, the fertilized murine oocytes were treated with BI2536 for 30 min after recovery from the oviduct to investigate the effect of down-regulation of Plk1 in the in vivo-fertilized murine embryos. Then, the localization and expression of Plk1 was observed by immunofluorescence staining. The sperm which had entered into the oocyte cytoplasm did not form male pronuclei in BI2536-treated oocytes. The BI2536-treated oocytes showed significantly lower expression of Plk1 than non-treated control group. In addition, alpha-tubulin and Plk1 gathered around sperm head in non-treated oocytes, while BI2536-treated oocytes did not show this phenomenon. The present study demonstrates that the Plk1 inhibitor, BI2536, hinders fertilization by inhibiting the formation of murine male pronucleus.
Keywords
Polo-like kinase 1 (Plk1); Alpha-tubulin (${\alpha}$-tubulin); BI2536; Developmental rate; Fertilization;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lane HA, Nigg EA. 1996. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J Cell Biol. 135:1701-1713.   DOI
2 Lee KS, Oh DY, Kang YH, Park JE. 2008. Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction. Cell Div. 3:4.   DOI
3 Li Z, Liu J, Li J, Kong Y, Sandusky G, Rao X, Liu Y, Wan J, Liu X. 2017. Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice. J Biol Chem. 42:17461-17472.
4 Liao Y, Lin D, Cui P, Abbasi B, Chen C, Zhang Z, Zhang Y, Dong Y, Rui R, Ju S. 2018. Polo-like kinase 1 inhibition results in misaligned chromosomes and aberrant spindles in porcine oocytes during the first meiotic division. Reprod Domest Anim. 53:256-265.   DOI
5 Mao Y, Xi L, Li Q, Cai Z, Lai Y, Zhang X, Yu C. 2016. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1. Oncol Rep. 36:49-56.   DOI
6 Merrick DT, Edwards MG, Franklin WA, Sugita M, Keith RL, Miller YE, Friedman MB, Dwyer-Nield LD, Tennis MA, O'Keefe MC, Donald EJ, Malloy JM, van Bokhoven A, Wilson S, Koch PJ, O'Shea C, Coldren C, Orlicky DJ, Lu X, Baron AE, Hickey G, Kennedy TC, Powell R, Heasley L, Bunn PA, Geraci M, Nemenoff RA. 2018. Altered cell-cycle control, inflammation, and adhesion in high-risk persistent bronchial dysplasia. Cancer Res. 78:4971-4983.   DOI
7 Mross K, Dittrich C, Aulitzky WE, Strumberg D, Schutte J, Schmid RM, Hollerbach S, Merger M, Munzert G, Fleischer F, Scheulen ME. 2012. A randomised phase II trial of the Polo-like kinase inhibitor BI2536 in chemo-naive patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network. Br J Cancer. 107:280-286.   DOI
8 Shao C, Ahmad N, Hodges K, Kuang S, Ratliff T, Liu X. 2015. Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer. J Biol Chem. 290:2024-2033.   DOI
9 Noor A, Umelo IA, Kronenberger P, Giron P, De Vlieghere E, De Wever O, Teugels E, De Greve J. 2018. Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer. Oncotarget. 9:28731-28744.
10 Schmucker and Sumara. 2014. Molecular dynamics of PLK1 during mitosis. Mol Cell Oncol. 1:e954507.   DOI
11 Sunkel CE, Glover DM. 1988. polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J Cell Sci. 1:25-38.
12 Steegmaier M, Hoffmann M, Baum A, Lenart P, Petronczki M, Krssak M, Gurtler U, Garin-Chesa P, Lieb S, Quant J, Grauert M, Adolf GR, Kraut N, Peters JM, Rettig WJ. 2007. BI2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol. 17:316-322.
13 Sumara I, Gimenez-Abian JF, Gerlich D, Hirota T, Kraft C, de la Torre C, Ellenberg J, Peters JM. 2004. Roles of polo-like kinase 1 in the assembly of functional mitotic spindles. Curr Biol. 14:1712-1722.   DOI
14 Wang H, Choe MH, Lee IW, Namgoong S, Kim JS, Kim NH, Oh JS. 2017. CIP2A acts as a scaffold for CEP192-mediated microtubule organizing center assembly by recruiting Plk1 and aurora A during meiotic maturation. Development. 144:3829-3839.   DOI
15 Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, Altmannsberger HM, Rübsamen-Waigmann H, Strebhardt K. 1997. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene. 14:543-549.   DOI
16 Yan W, Yu H, Li W, Li F, Wang S, Yu N, Jiang Q. 2018. Plk1 promotes the migration of human lung adenocarcinoma epithelial cells via STAT3 signaling. Oncol Lett. 5:6801-6807.
17 Zhao Y, Ai J, Zhang H, Zhu G. 2010. Polo-like kinase-1 regulates first cleavage of one-cell embryos in culture during assisted reproduction. Saudi Med J. 31:247-252.
18 Yao D, Gu P, Wang Y, Luo W, Chi H, Ge J, Qian Y. 2018. Inhibiting polo-like kinase 1 enhances radiosensitization via modulating DNA repair proteins in non-small-cell lung cancer. Biochem Cell Biol. 3:317-325.
19 Zhang Z, Chen C, Cui P, Liao Y, Yao L, Zhang Y, Rui R, Ju S. 2017. Plk1 inhibition leads to a failure of mitotic division during the first mitotic division in pig embryos. J Assist Reprod Genet. 34:399-407.   DOI
20 Zhang Z, Chen C, Ma L, Yu Q, Li S, Abbasi B, Yang J, Rui R, Ju S. 2017. Plk1 is essential for proper chromosome segregation during meiosis I/meiosis II transition in pig oocytes. Reprod Biol Endocrinol. 15:69.   DOI
21 Choi M, Kim W, Cheon MG, Lee CW, Kim JE. 2015. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells. Cancer Lett. 357:591-601.   DOI
22 Archambault V, Glover DM. 2009. Polo-like kinases: conservation and divergence in their functions and regulation. Nat. Rev. Mol. Cell. Biol. 10:364.   DOI
23 Baran V, Solc P, Kovarikova V, Rehak P, Sutovsky P. 2013. Polo-like kinase 1 is essential for the first mitotic division in the mouse embryo. Mol Reprod Dev. 80:522-534.   DOI
24 Baran V, Brzakova A, Rehak P, Kovarikova V, Solc P. 2016. PLK1 regulates spindle formation kinetics and APC/C activation in mouse zygote. Zygote. 24:338-345.   DOI
25 Brennan IM, Peters U, Kapoor TM, Straight AF. 2007. Polo-like kinase controls vertebrate spindle elongation and cytokinesis. PLoS One. 2:e409.   DOI
26 Cheng CY, Liu CJ, Huang YC, Wu SH, Fang HW, Chen YJ. 2018. BI2536 induces mitotic catastrophe and radiosensitization in human oral cancer cells. Oncotarget. 9:21231-21243.
27 Colicino EG, Garrastegui AM, Freshour J, Santra P, Post DE, Kotula L, Hehnly H. 2018. Gravin regulates centrosome function through PLK1. Mol Biol Cell. 29:532-541.   DOI
28 Gutteridge RE, Ndiaye MA, Liu X, Ahmad N. 2016. Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics. Mol Cancer Ther. 15:1427-1435.   DOI
29 Frost A, Mross K, Steinbild S, Hedbom S, Unger C, Kaiser R, Trommeshauser D, Munzert G. 2012. Phase i study of the Plk1 inhibitor BI2536 administered intravenously on three consecutive days in advanced solid tumours. Curr Oncol. 19:e28-35.
30 Gohda J, Suzuki K, Liu K, Xie X, Takeuchi H, Inoue JI, Kawaguchi Y, Ishida T. 2018. BI2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1. Sci Rep. 8:3521.   DOI
31 Kang YH, Park JE, Yu LR, Soung NK, Yun SM, Bang JK, Seong YS, Yu H, Garfield S, Veenstra TD, Lee KS. 2006. Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation. Mol Cell. 24:409-422.   DOI
32 Ha GH, Kim DY, Breuer EK, Kim CK. 2018. Combination treatment of Polo-like kinase 1 and tankyrase-1 inhibitors enhances anticancer effect in triple-negative breast cancer cells. Anticancer Res. 38:1303-1310.
33 Hauf S, Roitinger E, Koch B, Dittrich CM, Mechtler K, Peters JM. 2005. Dissociation of cohesin from chromosome arms and loss of arm cohesion during early mitosis depends on phosphorylation of SA2. PLoS Biol. 3:e69.   DOI
34 Jeong SB, Im JH, Yoon JH, Bui QT, Lim SC, Song JM, Shim Y, Yun J, Hong J, Kang KW. 2018. Essential role of Polo-like kinase 1 (Plk1) oncogene in tumor growth and metastasis of tamoxifen-resistant breast cancer. Mol Cancer Ther. 17:825-837.   DOI
35 Kheilova K, Petr J, Zalmanova T, Kucerova-Chrpova V, Rehak D. 2015. Src family kinases are involved in the meiotic maturation of porcine oocytes. Reprod Fertil Dev. 27:1097-1105.   DOI